First-line gefitinib in Caucasian EGFR mutation-positive...

British Journal of Cancer 2014 / 01 Vol. 110; Iss. 1

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

Douillard, J-Y, Ostoros, G, Cobo, M, Ciuleanu, T, McCormack, R, Webster, A, Milenkova, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
110
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.721
Date:
January, 2014
File:
PDF, 334 KB
english, 2014
Conversion to is in progress
Conversion to is failed